DNAStar said this week that Dalhousie Medicine New Brunswick, DMNB, has purchased a site license for Lasergene, its software for genome sequence assembly and analysis.
Under the terms of the agreement, faculty, staff, and scientists at the institution will have access to the software capabilities for their projects. "This software will help in the training of a new generation of physicians and is a step toward patient tailored therapy," Keith Brunt, an assistant professor at DMNB, said in a statement. He also said that the agreement will help "support the future success and growth of our program."
The financial details of the agreement were not disclosed.